Form 4: Vir Biotechnology EVP Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Sung Lee, EVP & Chief Financial Officer of Vir Biotechnology, sold 6,008 shares of common stock on March 27, 2024, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On March 27, 2024, Sung Lee, the EVP & Chief Financial Officer of Vir Biotechnology, Inc., sold 6,008 shares of the company's common stock.
- The sale was executed at a price of $9.8875 per share.
- This transaction was conducted to cover the issuer's tax withholding and remittance obligation associated with the vesting of restricted stock units.
- Following the transaction, Lee directly owns 100,492 shares of Vir Biotechnology.
Sentiment
Score: 6
Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction to cover tax obligations. It doesn't inherently suggest positive or negative sentiment, but the sale itself could be perceived neutrally.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and do not necessarily indicate a negative outlook on the company's future.
Key Dates
| Date | Description |
|---|---|
| 03/27/2024 | Date of the stock sale transaction. |
| 03/28/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.